<?xml version="1.0" encoding="UTF-8"?>
<notes>
 <p content-type="self-citation">
  <mixed-citation publication-type="journal" id="cas13513-cit-1001">
   <string-name>
    <surname>Ohmachi</surname>
    <given-names>K</given-names>
   </string-name>, 
   <string-name>
    <surname>Ando</surname>
    <given-names>K</given-names>
   </string-name>, 
   <string-name>
    <surname>Ogura</surname>
    <given-names>M</given-names>
   </string-name>, et al. 
   <article-title>E7777 in Japanese patients with relapsed/refractory peripheral and cutaneous T‐cell lymphoma: A phase I study</article-title>. 
   <source>Cancer Sci</source>. 
   <year>2018</year>;
   <volume>109</volume>:
   <fpage>794</fpage>–
   <lpage>802</lpage>. 
   <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/cas.13513" xmlns:xlink="http://www.w3.org/1999/xlink">https://doi.org/10.1111/cas.13513</ext-link>
  </mixed-citation>
 </p>
 <fn-group id="cas13513-ntgp-0001">
  <fn fn-type="funding" id="cas13513-note-1001">
   <p>
    <bold>Funding Information</bold>
   </p>
   <p>Eisai Co., Ltd.</p>
  </fn>
 </fn-group>
</notes>
